Bioprocessing - Upstream & Downstream

We get the story behind the development of Spiroligomer molecules and how they can help drug the undruggable.

The career path of Moncef Slaoui has resulted in billions of doses of lifesaving vaccines. Here he shares his story.

How do you design, refine, and optimize novel GLP-1 drugs that could improve patient experiences? With a computer, of course.

General Manager for the Irish commercial affiliate, Karen Costello, returns to her native country to help get medicines to Irish patients faster.

Experts look at trends in antibody drug development, including the growing popularity of new modalities.

Study investigates why vial choices matters for frozen biopharmaceutical storage.

We speak with Sanofi’s Anju Bhalla about its appeal against NICE’s final draft guidance for Sarclisa.

A look at how biosimilars can increase patient access to essential medicines, as well as improve performance in healthcare systems.

A selection of experts from Asahi Kasei Bioprocess discuss the key practices behind successful processes.

Understanding how choices in chromatography solutions impact overall process efficiency.